Search for Clinical Trial Results

Sponsored By

IgA Nephropathy - 15 Studies Found

Status Study
Completed Study Name: A Study to Evaluate the Efficacy and Safety of RO7434656 in Participants With Primary Immunoglobulin A (IgA) Nephropathy at High Risk of Progression
Condition: Primary IgA Nephropathy
Date: 2025-08-02
Interventions: RO7434656 will be administered subcutaneously per schedule as specified.
Completed Study Name: A Study of BION-1301 in Adults With IgA Nephropathy
Condition: IgA Nephropathy
Date: 2025-08-02
Interventions: BION-1301 Pre-Filled Syringe (PFS) 600mg subcutaneous administration every 2 weeks for 104 weeks.
Completed Study Name: Atacicept in Subjects With IgA Nephropathy
Condition: IgA Nephropathy
Date: 2025-08-02
Interventions: Once weekly subcutaneous (SC) injections by prefilled syringe
Completed Study Name: A First in Human Study to Evaluate Safety, Tolerability, Pharmacology of HS-10390 in Healthy Subjects
Condition: IgA Nephropathy
Date: 2025-08-02
Interventions: Oral administration of specified dose of HS-10390
COMPLETED Study Name: Replication of the NefIgArd Trial of TRF-budesonide in Primary IgAN
Condition: Primary IgA Nephropathy
Date: 2025-08-02
Interventions: TARPEYO dispensing claim for any dose is exposure
<<< Previous